Summary
Nine patients with osteosarcoma were treated by chemotherapy combined with caffeine and surgery. All primary tumors showed complete histological response to preoperative chemotherapy consisting of three intraarterial infusions of cisplatin and caffeine without/with doxorubicin and two systemic high-dose methotrexate combined with vincristine. Limb-salvage surgery was performed in eight patients with marginal procedure, which led to the preservation of good limb function. Below-knee amputation was done in one patient with calcaneal osteosarcoma. There has been neither local recurrence nor lung metastasis in seven patients with conventional osteosarcoma during a median follow-up period of 28 months. Lung metastases leading to death were observed in one patient with small-cell osteosarcoma despite complete destruction of the primary tumor by preoperative chemotherapy. Chemotherapy combined with caffeine administration deserves further extensive and large-scale study in osteosarcoma.
References
Bacci G, Picci P, Ruggieri P, Mercuri M, Avella M, Capanna R, Brach Del Prever A, Mancini A, Ferruzzi A, Manfrini M, Campanacci M (1990) Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. Cancer 65:2539–2553
Benjamin RS, Chawla SP, Carrasco C, Raymond AK, Fanning T, Wallace S, Ayala AG, Murray J (1988) Arterial infusion in the treatment of osteosarcoma. In: Ryan JR, Baker LO (eds) Recent concepts in sarcoma treatment. Kluwer Dordrecht, pp 269–274
Dougherty JB, Kelsen D, Kemeny N, Magill G, Botet J, Niedzwiecki D (1989) Advanced pancreatic cancer: a phase I–II trial of cisplatin, high-dose cytarabine, and caffeine. J Natl Cancer Inst 81:1735–1738
Epelman S, Erstrada J, Jaffe N, Bianchi A (1990) Pediatric osteosarcoma. Successful retreatment of relapsed primary tumor and soft tissue recurrence with intraarterialcis-diamminedichloroplatin-II. Cancer 66:801–805
Jaffe N, Knapp J, Chuang VP, Wallace S, Ayala A, Murray J, Cangir A, Wang A, Benjamin RS (1983) Osteosarcoma: intra-arterial treatment of the primary tumor withcis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic and pharmacologic studies. Cancer 51:402–407
Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230
Stine KC, Hockenberry MJ, Harrelson J, Miner D, Falletta JM (1989) Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma. Cancer 63:848–853
Tateishi A, Miki H, Takeyama S, Ishii S, Yamawaki S, Yagi T, Kakizaki H, Chigira M, Takada N, Endo F, Kawano H, Osaka S, Higaki S, Hamada Y, Takeuchi S, Tomita K, Matsui H, Sinjo K, Daisaku H, Inoue O (1989) The effects of preoperative cisplatinum (CDDP) therapy for the purpose of limb salvage of osteosarcoma evaluated by multifactor evaluation method. In: Yamamuro T (ed) New developments for limb salvage in musculoskeletal tumors. Springer, Tokyo Berlin Heidelberg New York, pp 189–192
Tomita K, Tsuchiya H (1989a) Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn J Cancer Res 80:83–88
Tomita K, Tsuchiya H (1989b) Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma. Clin Ther 11:43–52
Tomita K, Tsuchiya H (1989c) Intermediate results and functional evaluation of limb-salvage surgery for osteosarcoma: an intergroup study in Japan. J Surg Oncol 41:71–76
Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Gobel U, Havers W, Henze G, Hinderfeld L, Hocker P, Jobke A, Jurgens H, Kabisch H, Preusser P, Prindull G, Ramach W, Ritter J, Sekera J, Treuner J, Wust G, Landbeck G (1984) Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol 2:617–624
Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfurst C, Berger J, Ritter J, Jurgens H, Gerein V, Graf N, Russe W, Gruemayer ER, Ertelt W, Kotz R, Preusser P, Prindull G, Brandeis W, Landbeck G (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337
Winkler K, Bieleck S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw G, Jurgens H, Ritter J, Kusnierz-Glaz G, Erttmann R, Gadicke G, Graf N, Landenstein R, Leyvraz S, Mertens R, Weinel P (1990) Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 66:1703–1710
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsuchiya, H., Yasutake, H., Yokogawa, A. et al. Effect of chemotherapy combined with caffeine for osteosarcoma. J Cancer Res Clin Oncol 118, 567–569 (1992). https://doi.org/10.1007/BF01211797
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01211797